Citations (32)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Alshaymaa M Alhabibi, Maisa A Wahab, Ahmed Khairy Sakr, Samar M Abd El-Hamid, Mohamed Yahia Zakaria, Azza Ali Althoqapy, Hanaa Mohammed Eid El Sayed, Sammar Ahmed Kasim, Hanan F Ibrahim, Ola I Saleh, Howida A Ahmed, Alaa H Sayed & Mahmoud Lotfy. (2023) The Diagnostic Utility of Natural Killer Cell Subsets in Deep Vein Thrombosis. Vascular Health and Risk Management 19, pages 779-787.
Read now
Read now
Jake A Rice, Jonathan Brewer, Tyler Speaks, Christopher Choi, Peiman Lahsaei & Bryan T Romito. (2021) The POCUS Consult: How Point of Care Ultrasound Helps Guide Medical Decision Making. International Journal of General Medicine 14, pages 9789-9806.
Read now
Read now
Kerstin Folkerts, Julie Broughton, Usman Sheikh & Sasha Mckaig. (2019) Cost-effectiveness of rivaroxaban versus apixaban for the initial treatment of venous thromboembolism and extended prevention of recurrences in the UK. Journal of Medical Economics 22:11, pages 1179-1191.
Read now
Read now
C. Browne, T. Lanitis, M. Hamilton, X. Li, R. Horbyluk, J. Mardekian, T. Kongnakorn & A. Cohen. (2017) Impact of apixaban vs low molecular weight heparin/vitamin k antagonist on hospital resource use in patients with venous thromboembolism. Journal of Medical Economics 20:1, pages 98-106.
Read now
Read now
Articles from other publishers (28)
Shunichiro Fujioka, Tadashi Kitamura, Fumiaki Shikata, Toshiaki Mishima, Yoshihiko Onishi, Haruna Araki, Hiroshi Goto, Akihiro Sasahara, Masaomi Fukuzumi, Shinzo Torii & Kagami Miyaji. (2022) Outcomes after Rivaroxaban Treatment of Extensive Deep Vein Thrombosis. Annals of Vascular Surgery 85, pages 246-252.
Crossref
Crossref
Deekonda Satheesh, B. Sreenivasulu, Bhavanam Sekhara Reddy, U. Rajasekhar Reddy, J. S. Chakradhar Saladi, P. Badrinath Gupta, Aaramadaka Sunil Kumar Reddy, Balakrishna Aegurla & Keloth Basavaiah. (2022) Synthesis and characterization of impurities of Apixaban drug substance—An anticoagulant. Journal of Heterocyclic Chemistry.
Crossref
Crossref
Wei Song, Tao Ma, Qianyue Cheng, Pengfei Wen, Jiayuan Wu, Linjie Hao, Binfei Zhang, Yakang Wang, Qiuyuan Wang & Yumin Zhang. (2022) Global Research Status and Trends in Venous Thromboembolism After Hip or Knee Arthroplasty From 1990 to 2021: A Bibliometric Analysis. Frontiers in Medicine 9.
Crossref
Crossref
Jacob M. Kirsch, Michael Gutman, Manan Patel, Alex Rondon, Matthew L. Ramsey, Joseph A. Abboud, Gerald R. Williams & Surena Namdari. (2021) Low-dose aspirin and the rate of symptomatic venous thromboembolic complications following primary shoulder arthroplasty. Journal of Shoulder and Elbow Surgery 30:7, pages 1613-1618.
Crossref
Crossref
Wesley A M Verhoogt, Jurek R T Pietrzak, Olufemi R Ayeni & Josip N Cakic. (2020) Post-operative oral chemoprophylaxis in patients undergoing hip arthroscopy mitigates VTE risk with a low side-effect profile. Journal of Hip Preservation Surgery 7:3, pages 524-532.
Crossref
Crossref
Asma Rashki Kemmak, Ali Abutorabi & Vahid Alipour. (2020) Economic Evaluation of Rivaroxaban Versus Enoxaparin for Prevention of Venous Thromboembolism After Total Knee Replacement and Total Hip Replacement: A Systematic Review. Clinical Drug Investigation 40:8, pages 715-725.
Crossref
Crossref
Jin Kyu Lee, Ja Wook Koo, Soo-Young Jeong, Sihoon Choi, Ki-Chul Park & Kyu-Tae Hwang. (2020) Perioperative symptomatic venous thromboembolism after immediate chemoprophylaxis in patients with pelvic and lower-extremity fractures. Scientific Reports 10:1.
Crossref
Crossref
Beth A. Taylor, Paul M. Parducci, Amanda L. Zaleski, Gregory A. Panza, Linda S. Pescatello & Paul D. Thompson. (2019) Venous thromboemboli associated with acute aerobic exercise: A review of case report commonalities. Scandinavian Journal of Medicine & Science in Sports 29:11, pages 1749-1754.
Crossref
Crossref
Catherine M. Rapp, Edward J. Shields, Brett P. Wiater & J. Michael Wiater. (2019) Venous Thromboembolism After Shoulder Arthoplasty and Arthroscopy. Journal of the American Academy of Orthopaedic Surgeons 27:8, pages 265-274.
Crossref
Crossref
F.‐R. Bertin, R.N. Rys, C. Mathieu, S. Laurance, C.A. Lemarié & M.D. Blostein. (2019) Natural killer cells induce neutrophil extracellular trap formation in venous thrombosis. Journal of Thrombosis and Haemostasis 17:2, pages 403-414.
Crossref
Crossref
Martin F. Reiner, Daniel Müller, Sara Gobbato, Odile Stalder, Andreas Limacher, Nicole R. Bonetti, Lisa Pasterk, Marie Méan, Nicolas Rodondi, Drahomir Aujesky, Anne Angelillo-Scherrer, Christian M. Matter, Thomas F. Lüscher, Giovanni G. Camici, Arnold von Eckardstein & Jürg H. Beer. (2019) Gut microbiota-dependent trimethylamine-N-oxide (TMAO) shows a U-shaped association with mortality but not with recurrent venous thromboembolism. Thrombosis Research 174, pages 40-47.
Crossref
Crossref
Joo Hee Kim, Kyung-Min Lim & Hye Sun Gwak. (2017) New Anticoagulants for the Prevention and Treatment of Venous Thromboembolism. Biomolecules & Therapeutics 25:5, pages 461-470.
Crossref
Crossref
Anthony J. Nastasi, Joseph K. Canner, Brandyn D. Lau, Michael B. Streiff, Jonathan K. Aboagye, Peggy S. Kraus, Deborah B. Hobson, Kyle J. Van Arendonk & Elliott R. Haut. (2017) Characterizing the relationship between age and venous thromboembolism in adult trauma patients: findings from the National Trauma Data Bank and the National Inpatient Sample. Journal of Surgical Research 216, pages 115-122.
Crossref
Crossref
Rupert Bauersachs & Norimichi Koitabashi. (2017) Overview of Current Evidence on the Impact of the Initial High Dose of the Direct Factor Xa Inhibitor Rivaroxaban on Thrombus Resolution in the Treatment of Venous Thromboembolism. International Heart Journal 58:1, pages 6-15.
Crossref
Crossref
M.F. Reiner, S. Stivala, A. Limacher, N.R. Bonetti, M. Méan, M. Egloff, N. Rodondi, D. Aujesky, C. von Schacky, T.F. Lüscher, G.G. Camici & J.H. Beer. (2017) Omega‐3 fatty acids predict recurrent venous thromboembolism or total mortality in elderly patients with acute venous thromboembolism. Journal of Thrombosis and Haemostasis 15:1, pages 47-56.
Crossref
Crossref
E.A. Meyer, E. Caroff & M.A. Riederer. 2017. Comprehensive Medicinal Chemistry III. Comprehensive Medicinal Chemistry III
556
599
.
Karen N. Zaghiyan, Harry C. Sax, Emily Miraflor, David Cossman, Willis Wagner, James Mirocha, Bruce Gewertz & Phillip Fleshner. (2016) Timing of Chemical Thromboprophylaxis and Deep Vein Thrombosis in Major Colorectal Surgery. Annals of Surgery 264:4, pages 632-639.
Crossref
Crossref
Tereza Lanitis, Robert Leipold, Melissa Hamilton, Dale Rublee, Peter Quon, Chantelle Browne & Alexander T. Cohen. (2016) Cost-effectiveness of Apixaban Versus Other Oral Anticoagulants for the Initial Treatment of Venous Thromboembolism and Prevention of Recurrence. Clinical Therapeutics 38:3, pages 478-493.e16.
Crossref
Crossref
Trond Børvik, Sigrid K. Brækkan, Kristin Enga, Henrik Schirmer, Ellen E. Brodin, Hasse Melbye & John-Bjarne Hansen. (2016) COPD and risk of venous thromboembolism and mortality in a general population. European Respiratory Journal 47:2, pages 473-481.
Crossref
Crossref
Tingming Fu, Fengyun Yang, Huaming Zhu, Huaxu Zhu & Liwei Guo. (2015) Rapid extraction and purification of lumbrokinase from Lumbricus rubellus using a hollow fiber membrane and size exclusion chromatography. Biotechnology Letters 38:2, pages 251-258.
Crossref
Crossref
S. Vollans, A. Chaturvedi, K. Sivasankaran, T. Madhu, Y. Hadland, V. Allgar & H.K. Sharma. (2015) Symptomatic venous thromboembolism following circular frame treatment for tibial fractures. Injury 46:6, pages 1108-1111.
Crossref
Crossref
E. A. Nutescu, C. Crivera, J. R. Schein & B. K. Bookhart. (2014)
Incidence of hospital readmission in patients diagnosed with
DVT
and
PE
: clinical burden of recurrent events
. International Journal of Clinical Practice 69:3, pages 321-327.
Crossref
Crossref
Rami A. Al-Horani & Umesh R. Desai. (2014) Designing Allosteric Inhibitors of Factor XIa. Lessons from the Interactions of Sulfated Pentagalloylglucopyranosides. Journal of Medicinal Chemistry 57:11, pages 4805-4818.
Crossref
Crossref
Myriam Létourneau, Quang Trinh Nguyen, François Harel, Alain Fournier & Jocelyn Dupuis. (2013) PulmoBind, an Adrenomedullin-Based Molecular Lung Imaging Tool. Journal of Nuclear Medicine 54:10, pages 1789-1796.
Crossref
Crossref
Taki Galanis & Geno J. Merli. (2013) New oral anticoagulants: prevention of VTE in phase III studies in total joint replacement surgery and the hospitalized medically-ill patients. Journal of Thrombosis and Thrombolysis 36:2, pages 141-148.
Crossref
Crossref
Kathleen J Pincus & Lauren M Hynicka. (2013) Prophylaxis of Thromboembolic Events in Patients with Nephrotic Syndrome. Annals of Pharmacotherapy 47:5, pages 725-734.
Crossref
Crossref
Ira Zaltz, Paul Beaulé, John Clohisy, Perry Schoenecker, Daniel Sucato, David Podeszwa, Rafael Sierra, Robert Trousdale, Young-Jo Kim & Michael B. Millis. (2011) Incidence of Deep Vein Thrombosis and Pulmonary Embolus Following Periacetabular Osteotomy. Journal of Bone and Joint Surgery 93:Supplement_2, pages 62-65.
Crossref
Crossref
Pancras C. Wong, Donald J. P. Pinto & Donglu Zhang. (2011) Preclinical discovery of apixaban, a direct and orally bioavailable factor Xa inhibitor. Journal of Thrombosis and Thrombolysis 31:4, pages 478-492.
Crossref
Crossref